Back to Results
First PageMeta Content
Biotechnology / University of Toronto / Emerging technologies / Induced stem cells / Stem cells / Gene therapy / University Health Network / Toronto Western Research Institute / Krembil Research Institute


AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu
Add to Reading List

Document Date: 2016-02-18 12:07:01


Open Document

File Size: 223,64 KB

Share Result on Facebook
UPDATE